Circulating microRNAs can predict chemotherapy-induced toxicities in patients being treated for primary breast cancer

MG Davey, R Abbas, EP Kerin, MC Casey… - Breast Cancer Research …, 2023 - Springer
Purpose Prescribing NAC for breast cancer is a pragmatic treatment strategy for several
reasons; however, certain patients suffer chemotherapy-induced toxicities. Unfortunately …

Impact of oncology pharmacy services on the management of chemotherapy-induced nausea and vomiting: A systematic review and meta-analysis

Y Shin, S Shin, H Ryu, J Lee… - American Journal of …, 2024 - academic.oup.com
Disclaimer In an effort to expedite the publication of articles, AJHP is posting manuscripts
online as soon as possible after acceptance. Accepted manuscripts have been peer …

Quality of life and its predictors among patients with metastatic cancer in Bangladesh: the APPROACH survey

R Rahman, L Mariam, R Su, C Malhotra, S Ozdemir - BMC Palliative Care, 2024 - Springer
Background This study aimed to assess the health-related quality of life (HRQOL)(physical,
functional, emotional, social, spiritual) and psychological (anxiety and depression) well …

Gene polymorphisms of TACR1 serve as the potential pharmacogenetic predictors of response to the neurokinin-1 receptor antagonist-based antiemetic regimens: a …

M Ghorbani, S Namazi, M Dehghani, F Razi… - Cancer Chemotherapy …, 2024 - Springer
Purpose The current candidate gene association study aims to investigate tag SNPs from
the TACR1 gene as pharmacogenetic predictors of response to the antiemetic guidelines …

Chemotherapy-induced Emesis: Experienced Burden in Life, and Significance of Treatment Expectations and Communication in Chemotherapy Care

Y Widgren, M Silén, I Wåhlin… - Integrative Cancer …, 2023 - journals.sagepub.com
Objective: Because antiemetics have become more effective and integrative therapies such
as acupuncture are used in combination with antiemetics, people receiving chemotherapy …

Risk Factors Associated with Chemotherapy-Induced Nausea and Vomiting Among Women with Breast Cancer Receiving Highly Emetogenic Chemotherapy …

W Yeo, NTY Ngai, CCH Yip, FKF Mo… - Cancer Management …, 2024 - Taylor & Francis
Purpose Although risk factors related to chemotherapy-induced nausea and vomiting (CINV)
have been identified in previous studies, only a few studies have evaluated the risk factors …

Retrospective analysis of real‐world prescribing data for managing cisplatin‐based chemotherapy‐induced nausea and vomiting in China

X Si, H Zhang, Q Ding, G Liu, L Huang… - Cancer Medicine, 2024 - Wiley Online Library
Background The current utilization of neurokinin‐1 receptor antagonists (NK1RAs) and the
impact of updated guidelines on prescription patterns of antiemetic drugs among Chinese …

Single Nucleotide Polymorphism Directed Antiemetic Treatment in Women With Breast Cancer Treated With Neo-or Adjuvant Chemotherapy: A Randomised …

D Oliva, BÅ Andersson, L Shamoun, N Lewin… - Anticancer …, 2023 - ar.iiarjournals.org
Background/Aim: The role of single nucleotide polymorphisms (SNPs) in the frequency and
intensity of chemotherapy-induced nausea and vomiting (CINV) in women with breast …

Certified nurse specialists in cancer nursing and prophylactic antiemetic prescription for chemotherapy patients

A Okuyama, Y Takemura, M Sasaki, A Goto - Supportive Care in Cancer, 2022 - Springer
Purpose The prevention of chemotherapy-induced nausea and vomiting (CINV), a common
chemotherapy side effect, should be attempted by oncology nurses. Certified nurses could …

[HTML][HTML] Aprepitant

MK Ritchie, A Kohli - 2019 - europepmc.org
Aprepitant - Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe PMC
Menu About Tools Developers Help Contact us Helpdesk Feedback Twitter Blog Tech blog …